Grow your business safely with CleveXel Pharma

All the information you need about CleveXel Pharma to develop and secure your business in France

C HOME > CORPORATES > CleveXel Pharma > BALANCE SHEET ( 2018-07-18)

THE LIST OF BALANCE SHEET : CleveXel Pharma

CORPORATEBOBACCESTABLISHMENTSMANAGERSFINANCE
Deposit Confidentiality closing date document
2022-09-02 Partially confidential 2021-12-31 Complete
2021-09-13 Partially confidential 2020-12-31 Complete
2018-07-18 Partially confidential 2017-12-31 Complete
2017-07-18 Public 2016-12-31 Complete
NameCLEVEXEL PHARMA
Siren790115026
Closing2017-12-31
Registry code 7501
Registration number 63197
Management number2017B19347
Activity code 7219Z
Closing date n-12016-12-31
Duration Fiscal year 12
Duration Fiscal year n-112
Filing date2018-07-18
Modification00 Annual accounts entered without anomaly
Balance sheet typeC : Complete
Currency codeEUR
ConfidentialityPartially confidential
Address75013 PARIS
1 - Assets (balance sheet)Gross amount year NAmortization year NNet year NNet year N-1
AF Concessions, Patents and Similar Rights 400.00 400.00 400.00
AH Goodwill 1.00 1.00 1.00
AP Buildings
AT Other tangible assets
BH Other financial assets 72.00 72.00 72.00
BJ TOTAL (I) 251 102.00 400.00 250 702.00 251 102.00
BL Raw materials, supplies 4 625.00 1 125.00 3 500.00 4 625.00
BX Customers and related accounts
BZ Other receivables 841 925.00 841 925.00 841 925.00
CF Cash and cash equivalents 1 635 982.00 1 635 982.00 1 635 982.00
CH Prepaid expenses 1 769.00 1 769.00 1 769.00
CJ TOTAL (II) 2 484 301.00 1 125.00 2 483 176.00 2 484 301.00
CO Grand total (0 to V) 2 735 403.00 1 525.00 2 733 878.00 2 735 403.00
CP Shares due in less than one year 72.00 72.00
CU Other investments 250 629.00 250 629.00 250 629.00
2 - Liabilities (balance sheet)Amount year NAmount year N-1
DA Share or individual capital 1 433 484.00 912 953.00 1 433 484.00
DB Share, merger, contribution premiums, etc. 261 642.00 32 174.00 261 642.00
DD Legal reserve (1) 128 030.00 128 030.00 128 030.00
DF Regulated reserves (1) 28 078.00 28 078.00 28 078.00
DG Other reserves 2 502 463.00 2 502 463.00 2 502 463.00
DH Retained earnings -3 393 730.00 4 137.00 -3 393 730.00
DI RESULTS FOR THE YEAR (Profit or Loss) -2 382 212.00 -3 397 868.00 -2 382 212.00
DL TOTAL (I) -1 422 245.00 209 967.00 -1 422 245.00
DN Conditional advances 19 500.00 19 500.00 19 500.00
DO TOTAL (II) 19 500.00 19 500.00 19 500.00
DP Provisions for Risks 62 502.00 47 502.00 62 502.00
DR TOTAL (IV) 62 502.00 47 502.00 62 502.00
DV Miscellaneous Loans and Financial Debts (4) 200 000.00 200 000.00 200 000.00
DX Trade payables and related accounts 893 836.00 879 477.00 893 836.00
DY Tax and social security liabilities 1 180 878.00 1 471 400.00 1 180 878.00
EA Other liabilities 1 799 407.00 221.00 1 799 407.00
EC TOTAL (IV) 4 074 121.00 2 551 098.00 4 074 121.00
EE Grand total (I to V) 2 733 878.00 2 828 067.00 2 733 878.00
EG Accrued income and payables due within one year 4 074 121.00 2 551 098.00 4 074 121.00
5 - Fixed assets increase - decreaseGross value at beginning of year - Item by itemRevaluation - DisposalsAcquisition - Gross value at year-end
0G ACQUISITIONS Total General Total 432 001.00 72.00 432 001.00
I2 DECREASES Loans and Financial Fixed Assets 19 302.00
I3 DECREASES Total Financial Fixed Assets 19 302.00 250 701.00
I4 DECREASES Grand Total 180 971.00 251 102.00
IO DECREASES Total including other intangible assets 48 830.00 401.00
IY DECREASES Total Tangible Fixed Assets 112 839.00
KD ACQUISITIONS Total including other intangible assets 49 231.00 49 231.00
LN ACQUISITIONS Total Tangible Fixed Assets 112 839.00 112 839.00
LQ ACQUISITIONS Total Financial Fixed Assets 269 931.00 72.00 269 931.00
6 - Depreciation Amount at beginning of yearIncrease: allocation for the yearDiminution repriseYear-end amount
0N DEPRECIATION Grand Total 129 719.00 24 661.00 153 980.00 129 719.00
PE DEPRECIATION Total including other intangible assets 49 230.00 48 830.00 49 230.00
QU DEPRECIATION Total Tangible Fixed Assets 80 489.00 24 661.00 105 150.00 80 489.00
7 - Provisions Amount at beginning of yearIncrease: allocation for the yearDiminution repriseYear-end amount
4A Provisions for litigation
5Z Total provisions for risks and expenses 47 502.00 15 000.00 47 502.00
6N Inventories and work in progress 1 125.00
7B Total provisions for depreciation 1 125.00
7C Grand total 47 502.00 16 125.00 47 502.00
UE of which provisions and reversals: - Operating 1 125.00
UJ - Exceptional 15 000.00
8 - Receivables and payablesGross amountAmount within 1 yearAmount 1 to 5 yearsAmount more than 5 years
8A Miscellaneous Loans and Financial Debts 200 000.00 200 000.00 200 000.00
8B Suppliers and Related Accounts 893 836.00 893 836.00 893 836.00
8C Staff and Related Accounts 49 034.00 49 034.00 49 034.00
8D Social Security and Other Social Organizations 574 447.00 574 447.00 574 447.00
8K Other liabilities (including liabilities related to repo transactions) 1 799 407.00 1 799 407.00 1 799 407.00
UT Other financial assets 72.00 72.00 72.00
UZ Social Security, other social security organizations 94 736.00 94 736.00
VB VAT 200 145.00 200 145.00
VM Income taxes 504 561.00 504 561.00
VQ Other Taxes, Duties, and Similar Debts 496 209.00 496 209.00 496 209.00
VR Miscellaneous debtors (including receivables related to repo transactions) 42 243.00 42 243.00
VS Prepaid expenses 1 769.00 1 769.00
VT TOTAL – STATEMENT OF RECEIVABLES 843 766.00 843 766.00 843 766.00
VW VAT 61 188.00 61 188.00 61 188.00
VY TOTAL – STATEMENT OF LIABILITIES 4 074 121.00 4 074 121.00 4 074 121.00
11 - Earnings appropriation & miscellaneous informationAmount for year NAmount for year N-1Amount 1 to 5 yearsAmount more than 5 years
YP Average staff number 6.00 6.00

all companies in France

Complete and comprehensive database.